文献速递胸部外周血管CTDSA

COVID-19 患者中的肺栓塞与深静脉血栓:系统综述与 Meta 分析

Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis.
PubMed 文献 · Radiology · 2020-12-15

该系统综述与 Meta 分析纳入 27 项研究、3342 例 COVID-19 患者,汇总肺栓塞发生率为 16.5%、深静脉血栓为 14.8%,住 ICU 患者肺栓塞发生率高于未住 ICU 者。D-二聚体诊断肺栓塞的 AUC 为 0.737,500 与 1000 μg/L 阈值敏感度高但特异度低;超过半数肺栓塞患者无深静脉血栓。

要点

  • COVID-19 患者肺栓塞汇总发生率 16.5%,深静脉血栓 14.8%,住 ICU 者肺栓塞更多见。
  • 肺栓塞患者中仅 42.4% 合并深静脉血栓,超过半数无深静脉血栓。
  • D-二聚体 500 μg/L 排除肺栓塞敏感度 96%、特异度 10%;1000 μg/L 敏感度 91%、特异度 24%。

核心结论

  • COVID-19 患者肺栓塞与深静脉血栓汇总发生率分别为 16.5% 和 14.8%,超过半数肺栓塞患者无深静脉血栓。
  • 用于排除肺栓塞的既有指南 D-二聚体阈值似乎适用于 COVID-19 患者。

研究设计与样本

  • 系统综述与 Meta 分析,检索 2020 年 1 月 1 日至 2020 年 6 月 15 日评估 COVID-19 患者肺栓塞或深静脉血栓发生率的研究。
  • 共纳入 27 项研究、3342 例 COVID-19 患者,采用随机效应模型汇总,并行 Meta 回归分析。
  • D-二聚体诊断肺栓塞的准确度基于多中心个体患者数据、用总结受试者工作特征曲线估计。

诊断标准与关键数值

  • 肺栓塞汇总发生率 16.5%(95%CI:11.6,22.9;I²=0.93),深静脉血栓汇总发生率 14.8%(95%CI:8.5,24.5;I²=0.94)。
  • 住 ICU 患者肺栓塞发生率 24.7%(95%CI:18.6,32.1),未住 ICU 患者为 10.5%(95%CI:5.1,20.2)。
  • 采用 CT 肺动脉造影普遍筛查的研究中肺栓塞更常见;肺栓塞患者中 42.4% 存在深静脉血栓。
  • D-二聚体诊断肺栓塞的 AUC 为 0.737;D-二聚体 500 μg/L 敏感度 96%、特异度 10%,1000 μg/L 敏感度 91%、特异度 24%。

临床应用与阅片要点

  • 报告 COVID-19 患者影像时需注意肺栓塞可能,住 ICU 患者肺栓塞发生率高于未住 ICU 者。
  • 肺栓塞患者中仅 42.4% 合并深静脉血栓,超过半数无深静脉血栓。
  • D-二聚体 500 与 1000 μg/L 阈值敏感度高但特异度低,用于排除肺栓塞的既有指南阈值似乎适用于 COVID-19 患者。

局限性

  • 肺栓塞汇总发生率异质性 I²=0.93,深静脉血栓汇总发生率异质性 I²=0.94。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The association of pulmonary embolism (PE) with deep vein thrombosis (DVT) in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic accuracy of D-dimer tests for PE is unknown. Purpose To conduct meta-analysis of the study-level incidence of PE and DVT and to evaluate the diagnostic accuracy of D-dimer tests for PE from multicenter individual patient data. Materials and Methods A systematic literature search identified studies evaluating the incidence of PE or DVT in patients with COVID-19 from January 1, 2020, to June 15, 2020. These outcomes were pooled using a random-effects model and were further evaluated using metaregression analysis. The diagnostic accuracy of D-dimer tests for PE was estimated on the basis of individual patient data using the summary receiver operating characteristic curve. Results Twenty-seven studies with 3342 patients with COVID-19 were included in the analysis. The pooled incidence rates of PE and DVT were 16.5% (95% CI: 11.6, 22.9; I2 = 0.93) and 14.8% (95% CI: 8.5, 24.5; I2 = 0.94), respectively. PE was more frequently found in patients who were admitted to the intensive care unit (ICU) (24.7% [95% CI: 18.6, 32.1] vs 10.5% [95% CI: 5.1, 20.2] in those not admitted to the ICU) and in studies with universal screening using CT pulmonary angiography. DVT was present in 42.4% of patients with PE. D-dimer tests had an area under the receiver operating characteristic curve of 0.737 for PE, and D-dimer levels of 500 and 1000 μg/L showed high sensitivity (96% and 91%, respectively) but low specificity (10% and 24%, respectively). Conclusion Pulmonary embolism (PE) and deep vein thrombosis (DVT) occurred in 16.5% and 14.8% of patients with coronavirus disease 2019 (COVID-19), respectively, and more than half of patients with PE lacked DVT. The cutoffs of D-dimer levels used to exclude PE in preexisting guidelines seem applicable to patients with COVID-19. © RSNA, 2020 Supplemental material is available for this article. See also the editorial by Woodard in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Suh YJ, Hong H, Ohana M, et al. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Radiology. 2020. PMID: 33320063. doi:10.1148/radiol.2020203557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。